SNAP-8 is the second-generation “Botox®-in-a-jar” peptide developed by Lipotec (Lubrizol). The extended sequence (Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂) provides greater stability and 30% stronger inhibition of the SNARE complex than Argireline®, resulting in more pronounced and longer-lasting reduction of expression lines. Clinical studies show up to 63% wrinkle depth reduction after 28 days at 10% concentration — making it the most powerful topical neuromodulator peptide currently available for cosmetic-science research.
Key Scientific
- High-purity SNAP-8 (≥ 98% by HPLC/MS, acetate salt form)
- Verified extended octapeptide sequence: Acetyl-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂
- Lyophilized powder for maximum long-term stability
- Full Certificate of Analysis (COA) with HPLC, MS, amino acid analysis, and in vitro SNAP-25 cleavage assay
- Manufactured in GMP-aligned, ISO-compliant facilities
- Ideal for advanced anti-wrinkle, expression line, and topical neuromodulator research
Research-Referenced Attributes (Based on scientific literature; not intended as therapeutic claims.)
- 30% more effective than Argireline® at inhibiting SNARE complex formation
- Up to 63% reduction in wrinkle depth after 28 days of 10% topical use (double-blind, n=30)
- Longer-lasting effect due to increased stability and deeper skin penetration
- Synergistic with Argireline®, Matrixyl® 3000, and hyaluronic acid for multi-mechanism anti-aging
- Excellent skin tolerance — non-irritating even at 10% concentration
- Valuable in advanced cosmetic formulation, expression line, and topical Botox®-alternative research
Why Researchers Choose Nationwide Peptides SNAP-8
- Exact Lipotec-patented extended sequence used in clinical anti-wrinkle studies
- Highest documented SNAP-25 inhibition among topical neuromodulator peptides
- Transparent analytical data (HPLC >98%, MS confirmation of full octapeptide)
- Trusted by cosmetic-science, dermatology, and formulation laboratories worldwide
- Competitive research pricing with bulk options